233 related articles for article (PubMed ID: 14745886)
1. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
Krynyckyi BR; Shim J; Lim I
Cancer; 2004 Feb; 100(3):654-5; author reply 655-6. PubMed ID: 14745886
[No Abstract] [Full Text] [Related]
2. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
Rietman JS; Dijkstra PU; Geertzen JH; Baas P; De Vries J; Dolsma W; Groothoff JW; Eisma WH; Hoekstra HJ
Cancer; 2003 Aug; 98(4):690-6. PubMed ID: 12910511
[TBL] [Abstract][Full Text] [Related]
3. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
[TBL] [Abstract][Full Text] [Related]
4. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
Krynyckyi BR; Kim CK
Cancer; 2004 Nov; 101(10):2367-8; author reply 2368-9. PubMed ID: 15484211
[No Abstract] [Full Text] [Related]
5. [Preoperative staging of axillary lymph nodes in breast cancer: ultrasonographic parameters and ultrasound-guided core needle biopsy].
Torres Sousa MY; Banegas Illescas ME; Rozas Rodríguez ML; Arias Ortega M; González López LM; Martín García JJ; Ruiz Ortega L
Radiologia; 2011; 53(6):544-51. PubMed ID: 21565373
[TBL] [Abstract][Full Text] [Related]
6. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
7. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
8. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma.
Schrenk P; Rieger R; Shamiyeh A; Wayand W
Cancer; 2000 Feb; 88(3):608-14. PubMed ID: 10649254
[TBL] [Abstract][Full Text] [Related]
9. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
[TBL] [Abstract][Full Text] [Related]
10. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
Ahlgren J; Holmberg L; Bergh J; Liljegren G
Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
[TBL] [Abstract][Full Text] [Related]
11. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
12. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
van Wely BJ; van den Wildenberg FJ; Gobardhan P; van Dalen T; Borel Rinkes IH; Theunissen EB; Wijsman JH; Ernst M; van der Pol CC; Madsen EV; Vles WJ; Wauters CA; de Wilt JH; Strobbe LJ
Eur J Surg Oncol; 2012 Oct; 38(10):925-31. PubMed ID: 22633152
[TBL] [Abstract][Full Text] [Related]
13. Results of sentinel node biopsy not affected by previous excisional biopsy.
Heuts EM; van der Ent FW; Kengen RA; van der Pol HA; Hulsewé KW; Hoofwijk AG
Eur J Surg Oncol; 2006 Apr; 32(3):278-81. PubMed ID: 16246516
[TBL] [Abstract][Full Text] [Related]
14. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
Port ER; Patil S; Stempel M; Morrow M; Cody HS
Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
[TBL] [Abstract][Full Text] [Related]
15. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
Crane-Okada R; Wascher RA; Elashoff D; Giuliano AE
Ann Surg Oncol; 2008 Jul; 15(7):1996-2005. PubMed ID: 18415650
[TBL] [Abstract][Full Text] [Related]
16. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
17. [Sentinel node biopsy and axillary clearence in early breast cancer--An algorithm with explanations and queries].
Cserni G
Magy Seb; 2016 Mar; 69(1):4-13. PubMed ID: 26901689
[TBL] [Abstract][Full Text] [Related]
18. [Seroma after axillary lymph node dissection in breast cancer].
Douay N; Akerman G; Clément D; Malartic C; Morel O; Barranger E
Gynecol Obstet Fertil; 2008 Feb; 36(2):130-135. PubMed ID: 18243754
[TBL] [Abstract][Full Text] [Related]
19. Recurrence in the axilla after sentinel lymph node biopsy for breast cancer.
Salmon RJ; Bouillet TH; Lewis JS; Clough KB
Eur J Surg Oncol; 2002 Mar; 28(2):199. PubMed ID: 11884060
[No Abstract] [Full Text] [Related]
20. Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection.
Baron RH; Fey JV; Raboy S; Thaler HT; Borgen PI; Temple LK; Van Zee KJ
Oncol Nurs Forum; 2002 May; 29(4):651-9. PubMed ID: 12011912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]